Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
Featured Showcases
Photonics West Showcase
Optics+Photonics Showcase
News
Menu
Verisante's
Verisante's "Aura" probe, shown here, is based on the same Raman spectroscopy platform as the "Core", and has been tested for a variety of cancer screening applications. The Charing Cross Hospital trial will be the first to use Raman during brain surgery. Credit: Verisante Technology.
© 2024 SPIE Europe
Top of Page